Celcuity Inc. short interest in 2022
In 2022, Celcuity Inc.'s disclosed short interest ran from 1.21% of shares outstanding on 14 Jan 2022 to 0.67% on 30 Dec 2022, a change of -0.54 percentage points. The year's high was 3.61% on 15 Jun 2022 and its low 0.67% on 30 Dec 2022, averaging 1.62% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.53 days on 28 Feb 2022. Full history: Celcuity Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 1.21% (14 Jan 2022)
- End of year
- 0.67% (30 Dec 2022)
- Change
- -0.54 pp
- High
- 3.61% (15 Jun 2022)
- Low
- 0.67% (30 Dec 2022)
- Average
- 1.62%
- Highest days to cover
- 11.53 (28 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 1.21% | 6.00 | |
| 31 Jan 2022 | 1.57% | 6.74 | |
| 15 Feb 2022 | 1.70% | 6.28 | |
| 28 Feb 2022 | 1.84% | 11.53 | |
| 15 Mar 2022 | 2.10% | 11.53 | |
| 31 Mar 2022 | 1.96% | 3.99 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 2.23% | 5.81 | |
| 29 Apr 2022 | 3.10% | 5.69 | |
| 13 May 2022 | 3.29% | 10.35 | |
| 31 May 2022 | 3.51% | 3.88 | 10-Q filed, results (8-K) |
| 15 Jun 2022 | 3.61% | 7.55 | |
| 15 Aug 2022 | 0.97% | 3.90 | results (8-K), 10-Q filed |
| 31 Aug 2022 | 0.76% | 3.18 | |
| 15 Sep 2022 | 0.92% | 2.71 | |
| 30 Sep 2022 | 0.92% | 2.32 | |
| 14 Oct 2022 | 0.84% | 1.64 | |
| 31 Oct 2022 | 0.74% | 11.12 | |
| 15 Nov 2022 | 0.70% | 11.51 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 0.73% | 10.12 | |
| 15 Dec 2022 | 0.68% | 5.30 | |
| 30 Dec 2022 | 0.67% | 1.97 |
See also: Celcuity Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.